FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3106915432> ?p ?o ?g. }

• W3106915432 abstract "Abstract Background Secondary prevention after acute coronary syndrome (ACS) mirrors a key position in the reduction of morbidity and mortality in this highly vulnerable patient population. Especially dual anti-platelet therapy (DAPT) – including aspirin plus a P2Y12 inhibitor – proved to be one of the most beneficial therapeutic approaches for the reduction of re-events and stent thrombosis. However, profound epidemiological measures on adherence to DAPT intake after ACS remain scare, but seem of major importance in terms of preventing fatal cardiac adverse events. Therefore, we aimed to investigate adherence to DAPT after ACS and its impact on patient outcome from an Austrian nationwide perspective. Methods Within this population-based national observation all patients presenting with ACS between 04/2011 and 8/2015 in Austria were enrolled. Patient characteristics and co-morbidities were assessed via the Austrian national health insurance system and elucidated according to ICD10 definitions. Adherence to DAPT was investigated according to handing in prescriptions for aspirin and P2Y12 inhibitors at local pharmacies. Patients were followed prospectively until the primary study endpoint (=mortality) was reached. Cox Regression hazard analysis was used to investigate the impact of non-adherence to DAPT on patient outcome and was adjusted for a comprehensive subset of confounders within the multivariate model. Results During the observation period a total of 22.331 patients (median age: 65 years [55–75]; male: 69.7% [n=15.176]) met the inclusion criteria. Patients presenting with the indication for oral anticoagulation (n=2165; 9.7%), individuals that died during the index event (n=151; 0.7%), patients that presented with a re-ACS (n=396; 1.7%) or those who were lost during follow-up (n=96; 0.4%) were not included within the final analysis. Of alarming importance 70.7% (n=15.792) of all patients presenting with ACS did not take DAPT as recommended by current guidelines. The highest rate of drug interruption/end of therapy was observed within the first month after the index event with almost 50% of all cases. During patient follow-up until 14 months after the index event 513 individuals died. Non-adherence to DAPT proved a strong an independent association with mortality with an adjusted hazard ratio of 1.25 (95% CI: 1.09–1.41; p&lt;0.001). (see Figure 1) Conclusion The present nationwide investigation highlighted an overall low adherence to DAPT after ACS, with the highest interruption/end of therapy rate within the first month after the index event. Since the intake of DAPT after ACS was associated with a 20% risk reduction for fatal cardiovascular events during the observation period, awareness in terms of drug-adherence and intensified patient follow-up should be promoted, in order to prevent fatal atherothrombotic events. Figure 1. Cumulative Mortality Funding Acknowledgement Type of funding source: None" @default.
• W3106915432 created "2020-12-07" @default.
• W3106915432 creator A5001951606 @default.
• W3106915432 creator A5009815463 @default.
• W3106915432 creator A5010186154 @default.
• W3106915432 creator A5019187509 @default.
• W3106915432 creator A5020704982 @default.
• W3106915432 creator A5020904267 @default.
• W3106915432 creator A5022037530 @default.
• W3106915432 creator A5033998677 @default.
• W3106915432 creator A5040146633 @default.
• W3106915432 creator A5048088612 @default.
• W3106915432 creator A5056767810 @default.
• W3106915432 creator A5086010315 @default.
• W3106915432 date "2020-11-01" @default.
• W3106915432 modified "2023-09-25" @default.
• W3106915432 title "Adherence to dual anti-platelet therapy after acute coronary syndrome and its impact on patient outcome" @default.
• W3106915432 doi "https://doi.org/10.1093/ehjci/ehaa946.3383" @default.
• W3106915432 hasPublicationYear "2020" @default.
• W3106915432 type Work @default.
• W3106915432 sameAs 3106915432 @default.
• W3106915432 citedByCount "0" @default.
• W3106915432 crossrefType "journal-article" @default.
• W3106915432 hasAuthorship W3106915432A5001951606 @default.
• W3106915432 hasAuthorship W3106915432A5009815463 @default.
• W3106915432 hasAuthorship W3106915432A5010186154 @default.
• W3106915432 hasAuthorship W3106915432A5019187509 @default.
• W3106915432 hasAuthorship W3106915432A5020704982 @default.
• W3106915432 hasAuthorship W3106915432A5020904267 @default.
• W3106915432 hasAuthorship W3106915432A5022037530 @default.
• W3106915432 hasAuthorship W3106915432A5033998677 @default.
• W3106915432 hasAuthorship W3106915432A5040146633 @default.
• W3106915432 hasAuthorship W3106915432A5048088612 @default.
• W3106915432 hasAuthorship W3106915432A5056767810 @default.
• W3106915432 hasAuthorship W3106915432A5086010315 @default.
• W3106915432 hasConcept C126322002 @default.
• W3106915432 hasConcept C168563851 @default.
• W3106915432 hasConcept C177713679 @default.
• W3106915432 hasConcept C203092338 @default.
• W3106915432 hasConcept C207103383 @default.
• W3106915432 hasConcept C2426938 @default.
• W3106915432 hasConcept C2777628954 @default.
• W3106915432 hasConcept C2777698277 @default.
• W3106915432 hasConcept C2777849778 @default.
• W3106915432 hasConcept C2778715236 @default.
• W3106915432 hasConcept C2908647359 @default.
• W3106915432 hasConcept C2909112448 @default.
• W3106915432 hasConcept C44249647 @default.
• W3106915432 hasConcept C500558357 @default.
• W3106915432 hasConcept C50382708 @default.
• W3106915432 hasConcept C71924100 @default.
• W3106915432 hasConcept C98274493 @default.
• W3106915432 hasConcept C99454951 @default.
• W3106915432 hasConceptScore W3106915432C126322002 @default.
• W3106915432 hasConceptScore W3106915432C168563851 @default.
• W3106915432 hasConceptScore W3106915432C177713679 @default.
• W3106915432 hasConceptScore W3106915432C203092338 @default.
• W3106915432 hasConceptScore W3106915432C207103383 @default.
• W3106915432 hasConceptScore W3106915432C2426938 @default.
• W3106915432 hasConceptScore W3106915432C2777628954 @default.
• W3106915432 hasConceptScore W3106915432C2777698277 @default.
• W3106915432 hasConceptScore W3106915432C2777849778 @default.
• W3106915432 hasConceptScore W3106915432C2778715236 @default.
• W3106915432 hasConceptScore W3106915432C2908647359 @default.
• W3106915432 hasConceptScore W3106915432C2909112448 @default.
• W3106915432 hasConceptScore W3106915432C44249647 @default.
• W3106915432 hasConceptScore W3106915432C500558357 @default.
• W3106915432 hasConceptScore W3106915432C50382708 @default.
• W3106915432 hasConceptScore W3106915432C71924100 @default.
• W3106915432 hasConceptScore W3106915432C98274493 @default.
• W3106915432 hasConceptScore W3106915432C99454951 @default.
• W3106915432 hasLocation W31069154321 @default.
• W3106915432 hasOpenAccess W3106915432 @default.
• W3106915432 hasPrimaryLocation W31069154321 @default.
• W3106915432 hasRelatedWork W10968283 @default.
• W3106915432 hasRelatedWork W11975991 @default.
• W3106915432 hasRelatedWork W18928876 @default.
• W3106915432 hasRelatedWork W2862113 @default.
• W3106915432 hasRelatedWork W3621267 @default.
• W3106915432 hasRelatedWork W4447781 @default.
• W3106915432 hasRelatedWork W7392772 @default.
• W3106915432 hasRelatedWork W8160596 @default.
• W3106915432 hasRelatedWork W890575 @default.
• W3106915432 hasRelatedWork W17635508 @default.
• W3106915432 isParatext "false" @default.
• W3106915432 isRetracted "false" @default.
• W3106915432 magId "3106915432" @default.
• W3106915432 workType "article" @default.